Abstract
To study the effectiveness of the MSC cold cap system to prevent chemotherapy-induced alopecia. The system was applied in 83 cancer patients (mean age 49.8 years) undergoing chemotherapy with alopecia-causing agents. Seven patients did not tolerate the system. Seventy-six patients were evaluable for assessment; 26 received anthracycline (group A), 33 taxane (group T), 5 anthracycline plus taxane (group AT), 7 intravenous etoposide (group E) and 5 ifosfamide with or without other alopecia-causing drugs (group I). In group A, 18 patients received conventional (subgroup Ac) and 8 high doses (subgroup Ah). In group T, 8 patients received docetaxel (subgroup D) and 25 paclitaxel (subgroup P). Alopecia grade 0-1 (Dean's system) was considered as treatment success. Grade 0-1 alopecia was achieved in 49/76 (64.5%) patients: group T 23/33 (69.6%), subgroup P 16/25 (64%) and subgroup D 7/8 (87.5%); group A 18/26 (69.2%), subgroup Ac 16/18 (88.8%) and subgroup Ah 2/8 (25%); group AT 1/5 (20%); group E 6/7 (85.7%), and group I 1/5 (20%). The MSC cold cap system is effective in preventing alopecia from anthracycline, etoposide or taxane but not from anthracycline-taxane combinations or ifosfamide-containing regimens.
Citations
Jun 15, 2012·Lasers in Medical Science·Tongyu Cao WikramanayakeJoaquin J Jimenez
Mar 19, 2008·Cell Stress & Chaperones·Joaquin J JimenezRichard Voellmy
Sep 12, 2007·Bone Marrow Transplantation·M MachadoS A Khan
Apr 28, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·C J G van den HurkJ W R Nortier
Mar 11, 2005·Expert Opinion on Investigational Drugs·Georgann A Poulos, Paradi Mirmirani
Jan 26, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Manon M C KomenCorina J G van den Hurk
Aug 21, 2012·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Gulbeyaz CanAdnan Aydiner
Jun 15, 2005·European Journal of Cancer Care·J Randall, E Ream
Mar 20, 2014·The British Journal of Dermatology·V KantiN Garcia Bartels
Dec 10, 2009·Psycho-oncology·Elizabeth L McGarveyB Eugene Parker
Nov 3, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lesley FallowfieldMichael Dixon
May 9, 2014·International Journal of Cancer. Journal International Du Cancer·Cheryl M Soref, William E Fahl
Mar 10, 2015·Clinical Breast Cancer·Tessa CiglerAnne Moore
Mar 10, 2017·Breast Cancer Research and Treatment·Hope S RugoJeff Voigt
Nov 2, 2018·JAMA Dermatology·Dustin H MarksAdam Friedman
May 8, 2013·The Oncologist·Manon M C KomenJohan W R Nortier
Mar 22, 2014·Molecular and Clinical Oncology·Eva M EkwallBengt G Sorbe
Jan 4, 2019·Indian Journal of Cancer·Marniza SaadAdlinda Alip
Sep 17, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ChristodoulouD V Skarlos